2013-03-13 10:12:29 - “The high demand and double-digit growth in the insulin segment is promising for the overall protein therapeutics market”, says RNCOS.

According to our new report, “Global Protein Therapeutics Market Forecast to 2015”, the high demand of insulin amongst the diabetic population and the double-digit growth likely to be reported in this segment will boost the overall protein therapeutics market. The high demand of insulin is backed by severely rising prevalence and new innovations in insulin delivery devices. A major opportunity lies in the emerging markets for insulin, especially in the BRIC nations. With large share of undiagnosed population and low number of insulinized people; growth prospects are promising. It is expected that the market will advance at a CAGR of around 10% during 2012-2015 to reach US$ 23.8 Billion.

According to a new research report by RNCOS, “Global Protein Therapeutics Market

Forecast to 2015”, protein-based therapies have become one of the most effective clinical methods to treat wide spectrum of diseases ranging from cancer to metabolic disorders. Backed by a robust advanced stage pipeline the global protein therapeutics market may grow at a CAGR of around 8% during 2012-2015. Amongst the various segments in this market, coagulation factors are expected to show sustained growth on account of the rising cases of Hemophilia and other blood clotting-related disorders. With products in the market like Avastin, Remicade, Herceptin, and Rituxan having blockbuster status almost each year, the mAbs segment in particular holds tremendous potential in terms of revenue generation.

The report provides an in-depth research and rational analysis of the current and expected status of the protein therapeutics market. It covers all the key aspects of the market and provides an in-depth insight into the key industry segments. It prudently analyzes all the industry segments in an effective manner by focusing on major players and products, recent developments, application support in terms of indications, geographical performance, and last but not the least, current and future market size. The report investigates the current market trends and elucidates their impact on the current and future market performance. A brief description and key developments with respect to industry players have also been provided. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM389.htm

Some of our Related Reports are:

- Interferon Market Forecast to 2015 (http://www.rncos.com/Report/IM431.htm)
- Insulin Market Forecast to 2015 (http://www.rncos.com/Report/IM430.htm)
- Human Growth Hormone Market Forecast to 2015 (http://www.rncos.com/Report/IM429.htm)
- Erythropoietin Market Forecast to 2015 (http://www.rncos.com/Report/IM428.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.